Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Carol M Ulloa, Allen Towfigh, Joseph SafdiehDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USAAbstract: Levetiracetam is a second-generation antiepileptic drug (AED) with a unique chemical structure and mechanism of action. The extended release f...
Saved in:
Main Authors: | Carol M Ulloa, Allen Towfigh, Joseph Safdieh |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/e44f6df13ed84c11b8e7bb96312495c7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
by: Cormier J, et al.
Published: (2013) -
Monotherapy for partial epilepsy: focus on levetiracetam
by: Antonio Gambardella, et al.
Published: (2008) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
by: Anna Kelemen, et al.
Published: (2010) -
Profile of perampanel and its potential in the treatment of partial onset seizures
by: Rheims S, et al.
Published: (2013) -
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
by: Weisenberg JLZ, et al.
Published: (2011)